Target intelligence / Profile preview

Reactive oxygen and nitrogen species (RONS) (RONS)

Target
RONS
Molecular classification
Reactive species, Free radicals, Oxidants, Other
01

Overview

Reactive oxygen and nitrogen species (RONS) are a diverse group of highly reactive, oxygen- and nitrogen-containing molecules that include both free radicals, such as superoxide and nitric oxide, and non-radical oxidants like hydrogen peroxide and peroxynitrite [3, 11]. They are primarily generated as byproducts of mitochondrial aerobic metabolism and by specialized enzymes like NADPH oxidases during the immune system's oxidative burst [4, 10]. At physiological levels, RONS serve as essential secondary messengers in redox signaling pathways that regulate cell proliferation, differentiation, and apoptosis [2, 11]. However, an imbalance between RONS production and the body's antioxidant defense mechanisms leads to oxidative and nitrosative stress, causing irreversible damage to DNA, proteins, and lipids [1, 6]. This molecular damage is a key driver in the pathogenesis of various conditions, including neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), cardiovascular disorders, and cancer [5, 11]. Therapeutic interventions focus on neutralizing these species using radical scavengers like Edaravone, which inhibits lipid peroxidation and protects cellular membranes, or by supplementing endogenous antioxidant systems with agents like N-acetylcysteine [5, 7, 13].

Other names
Reactive oxygen and nitrogen radical speciesROS/RNSFree radicalsOxidantsReactive oxygen speciesReactive nitrogen speciesPro-oxidants
02

Mechanism of action

Drugs targeting these species primarily act through direct free radical scavenging, neutralization of non-radical oxidants, inhibition of lipid peroxidation, and the upregulation of endogenous antioxidant enzymes to restore redox balance [5, 7, 12].

03

Biological functions

Signal transductionImmune responseApoptosisCell proliferationRedox homeostasisCell differentiation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetesInfectionKidney disease
05

Safety considerations

Interference with essential physiological redox signaling (mitohormesis) [11]Potential for pro-oxidant effects at high concentrations [3]Lack of specificity in targeting specific reactive species [2]Poor clinical translation of general antioxidant therapies [1]
06

Interacting drugs

Edaravone

8 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)4-hydroxynonenal (4-HNE)Protein carbonyls3-nitrotyrosine8-isoprostaneGlutathione (GSH/GSSG ratio)

Beyond the preview

Go deeper on Reactive oxygen and nitrogen species (RONS) (RONS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen and nitrogen species (RONS) (RONS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call